While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Ziva D. Cooper, PhD
Advertisement
Dr Cooper is the director of the UCLA Center for Cannabis and Cannabinoids in the Jane and Terry Semel Institute for Neuroscience and Human Behavior. She is also an associate professor-in-residence in the Department of Psychiatry and Biobehavioral Sciences at UCLA’s David Geffen School of Medicine.
Articles by Ziva D. Cooper, PhD
Advertisement
Latest Updated Articles
Current Treatments for Cannabis Use DisorderPublished: December 22nd 2022 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
Exploring CBT Approaches for Chronic Insomnia in Adults: A Systematic Review and Network Meta-Analysis
4
The Use of Aripiprazole for Bipolar Disorder
5
